Parallel (Other Pharmaceuticals and Biotechnology) Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 333
Employees
  • Latest Deal Type
  • PIPE
  • (Announced)
  • Latest Deal Amount
  • $225M
Latest Deal Amount
  • Investors
  • 5

Parallel (Other Pharmaceuticals and Biotechnology) General Information

Description

Developer of cannabis-based medical products intended to empower health and well-being. The company's offerings include a diverse portfolio of proprietary brands that are made available in a variety of footprints including flower, pre-rolls, vaporizer pens, tinctures, oral sprays, topical creams, time-released transdermal patches, soft gels and cannabis-infused products, enabling consumers to improve the quality of lives through the benefits of cannabinoids.

Contact Information

Formerly Known As
SH NewCo, Surterra Wellness
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Consumer Non-Durables
Internet Retail
Primary Office
  • 55 Ivan Allen Boulevard
  • Suite 900
  • Atlanta, GA 30308
  • United States

Parallel (Other Pharmaceuticals and Biotechnology) Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Parallel (Other Pharmaceuticals and Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. PIPE 22-Feb-2021 $225M 00000 Announced Profitable
7. Reverse Merger 22-Feb-2021 00000 00000 00.000 Announced Profitable
6. Later Stage VC (Series D) 27-Jun-2019 00000 00000 00.000 Completed Profitable
5. Later Stage VC (Series C) 06-Aug-2018 0000 000.00 00000 Completed Generating Revenue
4. Early Stage VC 25-Sep-2017 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 11-Dec-2016 0000 000.00 Completed Startup
2. Early Stage VC (Series A) $9M $9.8M Completed Startup
1. Seed Round 01-Jan-2014 $800K $800K Completed Startup
To view Parallel (Other Pharmaceuticals and Biotechnology)’s complete valuation and funding history, request access »

Parallel (Other Pharmaceuticals and Biotechnology) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 00,000,000 00.000000 000 00.00 00.00 00 00.00 00.000
Series BB 0,000,000 00.000000 000 00.00 00.00 00 00.00 0.00
Series A-4 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 604,100 $0.001000 $1.74 $1.74 1x $1.38 1.54%
Series A-1 370,000 $0.001000 $0.5 $0.5 1x $0.5 0.75%
To view Parallel (Other Pharmaceuticals and Biotechnology)’s complete cap table history, request access »

Parallel (Other Pharmaceuticals and Biotechnology) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cannabis-based medical products intended to empower health and well-being. The company's offerings include
Other Pharmaceuticals and Biotechnology
Atlanta, GA
333 As of 2021
00000
000000000 00000

00000000

. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla paria
00000 000000000000000 000 0000000000000
Chicago, IL
000 As of 0000
00000
0000000000 0 00000

00000 00

re et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi u
00000 000000000000000 000 0000000000000
Toronto, Canada
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parallel (Other Pharmaceuticals and Biotechnology) Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PharmaCann Venture Capital-Backed Chicago, IL 000 00000 0000000000 0 00000
00000 00000000 000 Corporation Toronto, Canada 000 000.00 00000000 000.00
00000 00000 000000 Corporation Chicago, IL 0000 00000 000000000 00000
0000000 00000000 Formerly PE-Backed New York, NY 000 00000 000000&0 00000
000000 0000 Formerly Angel backed Chicago, IL 0000 00000 000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Parallel (Other Pharmaceuticals and Biotechnology) Executive Team (15)

Name Title Board Seat Contact Info
William Wrigley Jr. Chief Executive Officer & Chairman
Jeremy Kunicki Chief Financial Officer
James Whitcomb Chief Development Officer
Stevens Sainte-Rose Chief Human Resources Officer
Edward Brown Chief of Brand Strategy Development & Board Member
You’re viewing 5 of 15 executive team members. Get the full list »

Parallel (Other Pharmaceuticals and Biotechnology) Board Members (10)

Name Representing Role Since
Edward Brown Parallel (Other Pharmaceuticals and Biotechnology) Chief of Brand Strategy Development & Board Member 000 0000
James Holmes III Self Chief of Strategy and Innovation & Board Member 000 0000
Jason Becker Parallel (Other Pharmaceuticals and Biotechnology) Board Member 000 0000
Kevin Fisher Parallel (Other Pharmaceuticals and Biotechnology) Board Member & Strategic Advisor 000 0000
Thomas Venables Parallel (Other Pharmaceuticals and Biotechnology) Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Parallel (Other Pharmaceuticals and Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Parallel (Other Pharmaceuticals and Biotechnology) Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Patron Spirits Other Minority 000 0000 000000 0
Poseidon Asset Management Venture Capital Minority 000 0000 000000 0
Wychwood Asset Management Asset Manager Minority 000 0000 000000 0
New World Health Family Office Minority 000 0000 000000 0
Valkyrie Capital Venture Capital Minority 000 0000 000000 0
To view Parallel (Other Pharmaceuticals and Biotechnology)’s complete investors history, request access »

Parallel (Other Pharmaceuticals and Biotechnology) Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000 0000000 01-Apr-2021 000000000000000000 00000 Specialty Retail
00000 00000000000 22-Feb-2021 000000000000000000 Special Purpose Acquisition Company (SPAC)
000000000 00000000 25-Jun-2019 000000000000000000 Drug Discovery 0000000 0000000 00.
000 0000000 000000 21-Jun-2019 000000000000000000 Other Healthcare Services 0000000 0000000 00.
The Apothecary Shoppe (Las Vegas) 11-Dec-2018 Merger/Acquisition Pharmaceuticals 0000000 0000000 00.
To view Parallel (Other Pharmaceuticals and Biotechnology)’s complete acquisitions history, request access »

Parallel (Other Pharmaceuticals and Biotechnology) Subsidiaries (3)

Company Name Industry Location Founded
Molecular Infusions Drug Discovery Franklin, MA 2016
000 0000000 000000 Other Healthcare Services Brookline, MA 0000
000 0000000000 000 Pharmaceuticals Las Vegas, NV 0000
To view Parallel (Other Pharmaceuticals and Biotechnology)’s complete subsidiaries history, request access »